SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Genetown
Five Lessons Big Pharma Should Learn From Valeant’s Collapse
March 18, 2016
 · 
1 min read
Former Valeant CEO Nabs $9+ Million Severance Deal and Consulting Role
Business
Valeant CEO Reassures Employees Firm Isn’t Going Broke Even After Stock Continues its Nosedive
March 18, 2016
 · 
2 min read
Former Valeant CEO Nabs $9+ Million Severance Deal and Consulting Role
Business
Valeant CEO Lays Out Strategy to Staff, Says ‘No Other Shoe Expected to Drop’
March 11, 2016
 · 
2 min read
Business
Valeant Reassures Investors Top Dermatology Exec Resigned, Was Not Let Go As Part of Philidor Fallout
March 4, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Biotech Beach
Embattled Valeant Quietly Schedules Then Cancels Call with Analysts
March 1, 2016
 · 
3 min read
Business
Valeant CEO Pearson Returns, But Company Still Faces Numerous Challenges
February 29, 2016
 · 
3 min read
Business
Valeant CEO Pearson Ready to Return But Board is Debating Whether He Should
February 25, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Policy
As Valeant Drops $6 Billion+ in Value Over Four Days, Report Shows Interim CEO Used Company Jet for Vacation
February 23, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Valeant Uses Rare Accounting Move to Hide the True Details of Complex Deals
February 12, 2016
 · 
3 min read
Load More
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
 · 
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
 · 
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
 · 
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
 · 
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
 · 
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
 · 
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
 · 
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
 · 
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
 · 
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
 · 
4 min read
Load More